Ng CK - Search Results

1

Key considerations in the preclinical development of biosimilars.

Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM. Bui LA, et al. Among authors: ng ck. Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23. Drug Discov Today. 2015. PMID: 25912284 Review.

2

Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®).

Ryan AM, Sokolowski SA, Ng CK, Shirai N, Collinge M, Shen AC, Arrington J, Radi Z, Cummings TR, Ploch SA, Stephenson SA, Tripathi NK, Hurst SI, Finch GL, Leach MW. Ryan AM, et al. Among authors: ng ck. Toxicol Pathol. 2014 Oct;42(7):1069-81. doi: 10.1177/0192623313520351. Epub 2014 Mar 6. Toxicol Pathol. 2014. PMID: 24604381

3

Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence.

Jacobs I, Petersel D, Shane LG, Ng CK, Kirchhoff C, Finch G, Lula S. Jacobs I, et al. Among authors: ng ck. BioDrugs. 2016 Dec;30(6):489-523. doi: 10.1007/s40259-016-0199-9. BioDrugs. 2016. PMID: 27807766 Free PMC article. Review.

4

Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®)).

Hurst S, Ryan AM, Ng CK, McNally JM, Lorello LG, Finch GL, Leach MW, Ploch SA, Fohey JA, Smolarek TA. Hurst S, et al. Among authors: ng ck. BioDrugs. 2014 Oct;28(5):451-9. doi: 10.1007/s40259-014-0103-4. BioDrugs. 2014. PMID: 25001079 Free PMC article.

5

Tracing tumor heterogeneity of pleomorphic carcinoma of the lung.

Roma L, Ercan C, Conticelli F, Akyürek N, Prince SS, Mertz KD, Diebold J, Lardinois D, Piscuoglio S, Ng CK, Bubendorf L. Roma L, et al. Among authors: ng ck. J Thorac Oncol. 2024 May 7:S1556-0864(24)00205-3. doi: 10.1016/j.jtho.2024.04.019. Online ahead of print. J Thorac Oncol. 2024. PMID: 38723776

6

Use of patient-reported experience and outcome measures within the colorectal cancer care continuum: a scoping review.

Lau J, Ng JS, Lee D, Tan JK, Tan LL, Pang NQ, Tham SY, Ng CK, Tan KK. Lau J, et al. Among authors: ng ck. J Cancer Surviv. 2024 Apr 16. doi: 10.1007/s11764-024-01595-2. Online ahead of print. J Cancer Surviv. 2024. PMID: 38627293 Review.

7

Comparative evaluation of different modalities for measuring in vivo carnosine levels.

Amraotkar AR, Hoetker D, Negahdar MJ, Ng CK, Lorkiewicz P, Owolabi US, Baba SP, Bhatnagar A, O'Toole TE. Amraotkar AR, et al. Among authors: ng ck. PLoS One. 2024 Mar 27;19(3):e0299872. doi: 10.1371/journal.pone.0299872. eCollection 2024. PLoS One. 2024. PMID: 38536838 Free PMC article.

8

Comparative Study of Eclipse and RayStation Multi-Criteria Optimization-Based Prostate Radiotherapy Treatment Planning Quality.

Wong JYK, Leung VWS, Hung RHM, Ng CKC. Wong JYK, et al. Among authors: ng ckc. Diagnostics (Basel). 2024 Feb 20;14(5):465. doi: 10.3390/diagnostics14050465. Diagnostics (Basel). 2024. PMID: 38472938 Free PMC article.

9

Workplace violence in medical radiation science: A systematic review.

Shah KA, Ng CKC. Shah KA, et al. Among authors: ng ckc. Radiography (Lond). 2024 Mar;30(2):440-447. doi: 10.1016/j.radi.2023.12.018. Epub 2024 Jan 9. Radiography (Lond). 2024. PMID: 38199160 Free article.

10

Computed Tomography-Based Radiomics for Long-Term Prognostication of High-Risk Localized Prostate Cancer Patients Received Whole Pelvic Radiotherapy.

Leung VWS, Ng CKC, Lam SK, Wong PT, Ng KY, Tam CH, Lee TC, Chow KC, Chow YK, Tam VCW, Lee SWY, Lim FMY, Wu JQ, Cai J. Leung VWS, et al. Among authors: ng ckc. J Pers Med. 2023 Nov 24;13(12):1643. doi: 10.3390/jpm13121643. J Pers Med. 2023. PMID: 38138870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page